Key result
Highest stroke burden countries paradoxically report ~427 fewer MDD cases per 100,000 than lowest burden nations.
Why the study?
Although major depressive disorder is associated with increased stroke risk, the country-level ecological relationship between stroke burden and MDD prevalence remains unclear, and high-stroke settings may have under-recognized MDD due to differences in data availability, diagnostic practices, mental health services, and cultural symptom expression.
Observational (n=204)
Yes
Countries with the highest stroke burden report lower major depressive disorder prevalence, suggesting a potential diagnostic and reporting mismatch that supports integrating culturally adapted mental health screening into stroke-prevention strategies.
Answers are grounded in this paper and cite their sources.
May indicate underdiagnosis of MDD in high-stroke regions; hypothesis-generating for integrated screening pending individual-level data.
BACKGROUND: Major depressive disorder (MDD) is associated with increased stroke risk and can be conceptualized in Traditional Chinese Medicine (TCM) as emotional constraint or "Qi Stagnation" that may contribute to "Blood Stasis." However, the country-level ecological relationship between stroke burden and MDD prevalence remains unclear, and high-stroke settings may have under-recognized MDD because of differences in data availability, diagnostic practices, mental health services, and cultural symptom expression. This study quantifies this ecological association and interprets it through an Integrated Medicine framework. METHODS: Using Global Burden of Disease (GBD) 2023 data, we analyzed age-standardized stroke Disability-Adjusted Life Year (DALY) rates for all stroke and age-standardized prevalence rates for the GBD cause category of MDD across 204 countries and territories from 1990 to 2023. An exploratory Diagnostic Gap Score (ZStroke-ZMDD) was developed to identify countries and territories with disproportionate stroke burden relative to reported MDD prevalence. The highest stroke burden quartile (Q4) reported lower MDD prevalence (2639.9/100 000) than the lowest quartile (3067.0/100 000; mean difference 427.1/100 000, 95% CI: 121.52 to 732.58), despite an 8.3% increase in stroke burden in Q4. The score identified clusters with disproportionate stroke burden relative to MDD prevalence in Eastern Europe, Southeast Asia, and Pacific Island settings. CONCLUSIONS: Low reported MDD prevalence in high-stroke countries and territories suggests a potential diagnostic, reporting, or data-quality mismatch rather than biological protection. These ecological findings do not prove that undiagnosed MDD causes stroke burden, but they support culturally adapted mental health screening in primary care, stroke-prevention clinics, and community health settings, with referral pathways for those who screen positive.
No takes yet. Share an insight, caveat, or question.
Jia et al. (2026) conducted an observational in Stroke and major depressive disorder (MDD) (n=204). Highest stroke burden quartile (Q4, >2077.6 DALYs per 100,000) vs. Lowest stroke burden quartile (Q1, <=1086.8 DALYs per 100,000) was evaluated on Age-standardized major depressive disorder (MDD) prevalence rate per 100,000 population in 2023 (MD 427.05 per 100,000, 95% CI 121.52 to 732.58, p=0.007). Highest stroke burden countries (Q4) had lower reported MDD prevalence than lowest burden countries (Q1).
Synapse has enriched 10 related papers. Consider them for comparative context: